David Mehalick - CEO and President, Director, 10%+ Owner at Coeptis Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director, 10%+ Owner
Stock Symbol
COEP, COEPW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Mehalick since 4/23/2024

Holdings reported by David Mehalick for Coeptis Therapeutics Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Non-Qualified Stock Options (right to buy) 200K Mar 4, 2025 Direct Common Stock

Transactions reported by David Mehalick for Coeptis Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.